Navigation Links
Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
Date:7/31/2008

Conference Call and Webcast to Follow

ROCKVILLE, Md., July 31 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced it will release results for the second quarter ended June 30, 2008, on Tuesday, August 5, 2008, before the market opens. A full text copy of the release will be disseminated at that time.

Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer, will host a conference call to discuss the results and other corporate developments at 10:30 AM ET on Tuesday, August 5, 2008. Also participating on the call will be Steven A. Shallcross, Senior Vice President and CFO. To participate in the conference call, dial the appropriate number below shortly before the 10:30 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos.

The teleconference dial-in numbers are as follows:

Domestic callers 1-800-259-0251

International callers 1-617-614-3671

The conference call will be broadcast simultaneously and archived on the company's Web site, http://www.vandapharma.com . Investors should go to the Web site at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Tuesday, August 5, 2008, beginning at 12:30 PM ET and will be accessible until Thursday, September 4, 2008, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The access number is 985295
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
2. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
3. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
4. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
5. Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
6. Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights
7. Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
8. Poniard Pharmaceuticals Announces Upcoming Conference Participation
9. Indevus Pharmaceuticals to Announce Third Quarter Fiscal 2008 Financial Results on August 5, 2008
10. VioQuest Pharmaceuticals, Inc Valuation Upgrade Review Issued By Scimitar Equity, LLC
11. Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... The Gerresheimer,Group today opened a new plant ... production facility constructed in Danyang (Jiangsu Province),covers ... and cartridges for injection systems it serves ... a local and international level. Dr. Axel ...
... MISSISSAUGA, ON, May 28 /PRNewswire-FirstCall/ - YM BioSciences ... an oncology company that identifies, develops and commercializes ... a poster presentation will report results from a ... with head and neck cancer conducted by Biocon ...
... patient was supported with the,Berlin Heart EXCOR(R) Pediatric Ventricular ... first implantation of the device in 1990. The,patient, an ... in Chicago and has been successfully transplanted in the ... diagnosed a few weeks after birth with left,ventricular non ...
Cached Biology Technology:Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China 2Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China 3YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING 2YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING 3500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device 2
(Date:4/15/2014)... could know as early as 2020 how high sea levels ... of researchers including Florida International University scientist Rene Price. , ... Florida Coastal Everglades Long-Term Ecological Research (LTER) site, one of ... to deserts, mountains to salt marshes around the world. , ...
(Date:4/15/2014)... If an insect drew a line as it chased ... mess. But there,s method to that mess, says Jane Wang, ... tries to find simple physical explanations for complex, hardwired animal ... the tiger beetle, known for its speed and agility, does ...
(Date:4/15/2014)... The American Association of Anatomists (AAA) is honored to announce ... during the Closing Awards Ceremony being held at the San ... during AAA,s 2014 Annual Meeting at Experimental Biology (EB). ... Henry Gray/Elsevier Distinguished Educator Medal: Jeffrey Laitman, PhD, of ...
Breaking Biology News(10 mins):Long-term predictions for Miami sea level rise could be available relatively soon 2Photo: Tiger beetle's chase highlights mechanical law 2American Association of Anatomists 2014 award winners 2
... to differentiate between sweet and bitter tastes may reside in ... The study explains the discovery of a chemical messenger called ... long known that NPY is active in the brain and ... is also active in taste bud cells. , That finding ...
... help improve the effectiveness of chemotherapy at treating head ... Comprehensive Cancer Center have found. , The findings, which ... Cancer Therapeutics, could lead to a treatment that provides ... patients preserve vital organs involved in speech and swallowing. ...
... fast switch that uses water droplets to create adhesive bonds ... in palm beetles. , The new beetle-inspired switch, designed ... scale of a micron -- a millionth of a meter. ... like powerful adhesive bonding. Like the transistor, whose varied uses ...
Cached Biology News:Bitter or sweet? The same taste bud can tell the difference 2Bitter or sweet? The same taste bud can tell the difference 3Compound from Chinese medicine shows promise in head and neck cancer 2Compound from Chinese medicine shows promise in head and neck cancer 3Beetle-inspired switch uses water for bonding 2
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
... Goat polyclonal to Cholesterol Oxidase Immunogen ... Specificity Cross-reacts with bacteria. Not yet ... Cholesterol oxidases exist as both type ... implicated in bacterial pathogenesis. In addition, they ...
Phospho-PERK (Thr980) Antibody...
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
Biology Products: